G. Field

Patient specific treatment verifications for helical tomotherapy treatment plans.

B. Fallone, M. Mackenzie, A. Syme, 2005, Medical physics.

Dosimetric verification of inverse planned step and shoot multileaf collimator fields from a commercial treatment planning system

B. Fallone, M. Mackenzie, B. Murray, 2002, Journal of applied clinical medical physics.

Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.

G. Field, J. Hanson, M. Parliament, 2002, International journal of radiation oncology, biology, physics.

Shielding considerations for tomotherapy.

B. Fallone, D. Robinson, G. Field, 2000, Medical physics.

An evaluation of forward and inverse radiotherapy planning using Helax-TMS (version 6.0) for lung cancer patients treated with RTOG 93-11 dose-escalation protocol.

B. Murray, W. Roa, D. Robinson, 2003, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial.

Sunita Ghosh, G. Field, P. Cadman, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intravesical methotrexate in the treatment of superficial bladder cancer.

G. Field, G. Smith, T. Hargreave, 1984, British journal of urology.

Evaluation of optimized compensators on a 3D planning system.

P S Basran, W Ansbacher, B. Murray, 1998, Medical physics.

Dose calculations for megavoltage photon beams using convolution

G. Field, 1989 .